Científicos del St. Jude Children’s Research Hospital han demostrado que GRP78 es una diana prometedora pero compleja para la inmunoterapia con células CAR-T contra tumores cerebrales y sólidos. ...
Read moreThe Spanish Agency for Medicines and Health Products (AEMPS) defines them advanced therapies as medicines for human use that may be based on genes (gene therapy), cells (cellular therapy) or fabrics (...
Read moreHan puesto en marcha un ensayo clínico para evaluar la seguridad y la eficacia de esta nueva inmunoterapia celular adoptiva, propiedad del Hospital Clínic de Barcelona, el IDIBAPS y la UB, en pacien...
Read moreBuscarán avances en inmunoterapias ya establecidas en adultos, nuevos mecanismos de ataque a tumores cerebrales y la creación de organoides y ‘labs-on-a-chip’ para ensayar fármacos.
Read moreThermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software, a first-of-its-kind automation solution designed to connect and integrate work...
Read moreCERTERA's objective is to create a coordinated research and innovation structure to accelerate the preclinical and early stage clinical development of these types of therapies.
Read moreHan permitido desarrollar una estrategia totalmente nueva para fabricar dosis terapéuticas de células Treg a partir de un tejido que cubre el corazón y que se desecha habitualmente en el transcurso...
Read moreThe combined Group, named 3PBIOVIAN, will offer unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substance and Drug Pr...
Read moreLa Asociación Española Contra el Cáncer impulsa con su ayuda el trabajo científico en nuevos tratamientos contra el cáncer de páncreas, de mama o de pulmón.
Read moreThe research provides the most comprehensive cellular map to date of the human tonsil, increasing our understanding of immune response to disease, and perception of immune system related diseases such...
Read moreProceeds from the financing will be used to advance the company’s pipeline of wholly-owned, off-the-shelf cell therapies for multiple indications, including its lead investigational candidate, NRTX-...
Read more2023 in biomedical research has been full of incredible advances that bring us, step by step, closer to the future. From the production of green fertilisers that reduce their impact on the environment...
Read more